The recent initiation report on International Stem Cell Corporation (OTCQB: ISCO) by Edison Investment Research looks at the company from a novel perspective. Although described as ‘an early-stage cell therapy company currently in Phase I/IIa clinical trials to treat Parkinson’s disease (PD)’, the company is much more. It has two wholly-owned subsidiaries that are currently […]
The Stocks To Buy Now Blog
Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.